Technical Advisory Panel
-
{
- All
- News
- Videos
-
Telangana Government Onboards Digital Wallet Liminal on Web3-Focussed Advisory Panel: Details
Liminal, a digital wallet service provider, has joined forces with the Telangana government to nurture promising Web3 projects budding in the state. Telangana’s Web3 regulatory sandbox plans to help startups with management guidance, technical support, and business strategy for creating a sustainable business model.
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Expert Panel Deliberating On Vaccinating Children Against Covid: Centre
The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunization (NTAGI) are deliberating and considering scientific evidences related to vaccination of children, Rajya Sabha was info
-
Expert Panel Considering Evidence On Justification Of Booster Covid Vaccine Dose: Centre
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are considering scientific evidences related to justification for booster doses against Covid.
-
Additional Dose For Those At Risk? Covid Panel To Decide Today
The National Technical Advisory Group on Immunisation will meet tomorrow to discuss the administration of additional doses of the Covid vaccine to immunocompromised individuals, officials said.
-
WHO Panel To Decide On Covaxin Emergency Use On Wednesday
The Technical Advisory Group of World Health Organisation has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing risk-benefit assessment for global use of the vaccine.
-
Children With Comorbidities To Be Prioritised For Vaccination: Central Panel Chief
Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
-
Telangana Government Onboards Digital Wallet Liminal on Web3-Focussed Advisory Panel: Details
Liminal, a digital wallet service provider, has joined forces with the Telangana government to nurture promising Web3 projects budding in the state. Telangana’s Web3 regulatory sandbox plans to help startups with management guidance, technical support, and business strategy for creating a sustainable business model.
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Expert Panel Deliberating On Vaccinating Children Against Covid: Centre
The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunization (NTAGI) are deliberating and considering scientific evidences related to vaccination of children, Rajya Sabha was info
-
Expert Panel Considering Evidence On Justification Of Booster Covid Vaccine Dose: Centre
National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are considering scientific evidences related to justification for booster doses against Covid.
-
Additional Dose For Those At Risk? Covid Panel To Decide Today
The National Technical Advisory Group on Immunisation will meet tomorrow to discuss the administration of additional doses of the Covid vaccine to immunocompromised individuals, officials said.
-
WHO Panel To Decide On Covaxin Emergency Use On Wednesday
The Technical Advisory Group of World Health Organisation has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing risk-benefit assessment for global use of the vaccine.
-
Children With Comorbidities To Be Prioritised For Vaccination: Central Panel Chief
Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
